Answer
Co-amilofruse is not recommended during pregnancy because amiloride’s safety has not been established and furosemide crosses the placenta; despite clinical evidence of furosemide’s safety in the third trimester, it must not be given unless there are compelling medical reasons, and treatment requires monitoring of foetal growth.
Sources for this answer
- Co-Amilofruse 5/40mg TabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked